Pulmotect, Inc. Employee Directory
Biotechnology ResearchTexas, United States2-10 Employees
Pulmotect, Inc. is a small biotechnology research company based in Houston, Texas, focused on respiratory health through immune modulation. It has developed PUL-042, an inhaled therapy designed to stimulate the innate immune system to deliver targeted protection for the lungs against bacteria, fungi, and viral pathogens. The program sits in the clinical-stage space, advancing an inhaled immunomodulatory approach. The work centers on strengthening the lungs' defenses rather than treating infection directly. Earlier clinical activity includes reports of favorable findings from a Phase 2 study evaluating PUL-042 in the context of COVID-19. Based in Houston and maintaining a compact team, Pulmotect operates within the biotechnology research ecosystem as it advances its lead inhaled therapy.